We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Shining Light on Farm & Food Policy for 20 Years.
Tuesday, November 19, 2024
Namandjé Bumpus will step into the role of principal deputy commissioner at the Food and Drug Administration following the retirement of Janet Woodcock early next year, and Michael Rogers has been named associate commissioner for regulatory affairs.
Extensive internal and external feedback is leading the Food and Drug Administration to further refine a reorganizational plan to include clear responsibilities for the leader of the Human Foods Program and significant changes for its Office of Regulatory Affairs.
Stakeholders offered a tepid response to Food and Drug Administration Commissioner Robert Califf’s unveiling Tuesday of a new Humans Foods Program, which Califf said he believes will fundamentally transform the way FDA oversees the U.S. food supply.
The Food and Drug Administration is calling for a new “regulatory pathway” to allow for the use of use of cannabidiol, or CBD, in dietary supplements and food additives, after concluding that “it is not apparent how CBD products could meet safety standards” for those products.
FDA Commissioner Robert Califf, already grappling with the infant formula crisis, told lawmakers Thursday the agency lacks the leadership and staff to properly regulate food safety and appealed for more funding.
